Cefpodoxime Proxetil and Clavulanic Acid combination in Nepocef-CV Tablets provides broad-spectrum antibacterial protection for dogs suffering from skin, wound, respiratory, urinary, and ear infections. Specially formulated with flavoured, small-sized double-strength tablets, Nepocef-CV improves medication acceptance and ensures better compliance in long-duration treatments such as canine pyoderma.
Canine pyoderma treatment often requires extended antibiotic therapy, and poor compliance can lead to recurrence, resistance, and delayed healing. Nepocef-CV addresses this concern with once-daily dosing, easy administration, and enhanced palatability, making treatment simpler for pet parents and veterinarians alike.
The synergistic action of Cefpodoxime Proxetil and Clavulanic Acid helps combat both susceptible bacteria and beta-lactamase-producing resistant organisms. Cefpodoxime inhibits bacterial cell wall synthesis, while Clavulanic Acid neutralises bacterial resistance mechanisms, resulting in improved therapeutic efficacy.
Nepocef-CV is widely recommended for superficial and deep pyoderma, post-surgical infections, wounds, respiratory tract infections, urinary tract infections, and ear infections in dogs.
Key Benefits
- Broad-spectrum antibacterial activity for dogs
- Effective against beta-lactamase-producing resistant bacteria
- Flavoured tablets for better acceptance and reduced wastage
- Small double-strength tablets for easy administration
- Once-daily dosing improves treatment compliance
- Supports faster recovery and improved clinical outcomes
- Suitable for long-term pyoderma management
- Helps prevent recurrence and complications from incomplete treatment
- Accurate dosing for dogs of different body weights
- Trusted veterinary antibiotic combination therapy
Composition
Each tablet contains:
- Cefpodoxime proxetil – 162,5 mg / 325 mg
- Potassium Clavulanate (Clavulanic Acid)
Mechanism of Action
Cefpodoxime Proxetil
- Third-generation cephalosporin antibiotic
- Inhibits bacterial cell wall synthesis
- Effective against a wide range of gram-positive and gram-negative bacteria
Clavulanic Acid
- Beta-lactamase inhibitor
- Prevents bacterial resistance against cefpodoxime
- Enhances antibacterial effectiveness
Recommended For
- Canine Pyoderma
- Deep Pyoderma
- Superficial Pyoderma
- Wounds & Post-Surgical Infections
- Respiratory Tract Infections
- Urinary Tract Infections
- Ear Infections
- Cutaneous & Subcutaneous Infections
- Skin Abscesses
Dosage & Administration
- Recommended Dose: 5–10 mg per kg body weight
- Route: Oral
- Frequency: Once daily
Recommended Treatment Duration
Deep Pyoderma
- Minimum 17–21 days
- Continue 10–14 days after clinical remission
Superficial Pyoderma
- Minimum 9–15 days
- Continue for 7 days after clinical remission
Respiratory & Urinary Tract Infections
Wounds / Abscesses
Use strictly under veterinary supervision.
Pack Size
Why Compliance Matters in Canine Pyoderma
Incomplete antibiotic therapy is one of the major causes of recurrent pyoderma and antibiotic resistance in dogs. Nepocef-CV’s flavoured, easy-to-administer, once-daily tablets help pet parents complete the prescribed treatment course effectively, ensuring better recovery and minimising recurrence risk.
Product Information
| Attribute |
Details |
| Brand |
Nepocef-CV |
| Product Type |
Veterinary Antibiotic Tablets |
| Suitable For |
Dogs |
| Use For |
Bacterial Infections & Pyoderma |
| Form |
Flavored Tablets |
| Drug Class |
Cephalosporin Antibiotic + Beta-lactamase Inhibitor |
